To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF
Clinical trial NCT05497284 · TERMINATED
Trial details
- NCT number
- NCT05497284
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2024-08-26
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.